Histamine-induced cyclic AMP formation in the chick hypothalamus: Interaction with vasoactive intestinal peptide

Pharmacological Reports

Volumn 57, Issue 2, 2005, Pages 188-194

  Zawilska, Jolanta B ^a   Gendek Kubiak, Hanna ^a   Woldan Tambor, Agata ^a   Wiktorowska Owczarek, Anna ^a   Nowak, Jerzy Z ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chick; Cyclic AMP; Histamine; Hypothalamus; VIP

Indexed keywords

2 METHYLHISTAMINE; 4 METHYLHISTAMINE; AMINOPOTENTIDINE; AMTHAMINE; CIMETIDINE; CYCLIC AMP; DIMAPRIT; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; MEPYRAMINE; N ALPHA, N ALPHA DIMETHYLHISTAMINE; RANITIDINE; TELE METHYLHISTAMINE; THIOPERAMIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; ZOLANTADINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENZYME SYNTHESIS; HYPOTHALAMUS; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; REGULATORY MECHANISM; TISSUE SLICE;

EID: 20344395609     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP, Leceta J: Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune disease. J Mol Med 2002, 80, 16-24.
2. El Halawani ME, Silsby JL, Mauro LJ: Vasoactive intestinal peptide is a hypothalamic prolactin releasing neuropeptide in the turkey (Meleagris gallopavo). Gen Comp Endocrinol, 1999, 78, 66-73.
3. Gozes I, Brenneman DE: VIP: molecular biology and neurobiological function. Mol Neurobiol, 1989, 3, 201-236.
4. Gruol DL, Weinreich D: Two pharmacologically distinct histamine receptors mediating membrane hyperpolarization on identified neurons of Aplysia californica. Brain Res, 1979, 162, 282-301.
5. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR et al.: International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev, 1998, 50, 265-270.
6. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W et al.: Classification of histamine receptors. Pharmacol Rev, 1997, 49, 253-278.
7. Hof PR, Dietl MM, Charnay Y, Martin JL, Bouras C, Palacios JM, Magistretti PJ: Vasoactive intestinal peptide binding sites and fibers in the brain of the pigeon Columbia liva: an autoradiographic and immunohistochemical study. J Comp Neurol, 1991, 305, 393-411.
8. Hough LB: Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol, 2001, 59, 415-419.
9. Kansaku N, Shimada K, Ohkubo T, Saito N, Suzuki T, Matsuda Y, Zadwomy D: Molecular cloning of chicken vasoactive intestinal polypeptide receptor complementary DNA, tissue distribution and chromosomal localization. Biol Repr, 2001, 64, 1575-1581.
10. Knigge U, Warberg J: Neuroendocrine functions of histamine. Agents Actions, 1991, 33, Suppl., 29-53.
11. Kuenzel WJ, Mccune SK, Talbot RT, Sharp PJ, Hill JM: Sites of gene expression for vasoactive intestinal polypeptide throughout the brain of the chick (Gallus domesticus). J Comp Neurol, 1997, 381, 101-118.
12. Maney DL, Schoech SJ, Sharp PJ, Wingfield JC: Effects of vasoactive intestinal peptide on plasma prolactin in passerines. Gen Comp Endocrinol, 1999, 113, 323-330.
13. Meunier AC, Voisin P, Van Camp G, Cenatiempo Y, Muller JM: Molecular characterization and peptide specificity of two vasoactive intestinal peptide (VIP) binding sites in the chicken pineal. Neuropeptides, 1991, 19, 1-8.
14. Nassel DR: Histamine in the brain of insects: a review. Microsc Res Tech, 1999, 44, 121-136.
15. Nilsson A: Isolation, amino acid composition and terminal amino acid residues of the vasoactive ectacosapeptide from chicken intestine. Partial purification of chicken secretin. FEBS Lett, 1974, 47, 284-289.
16. Nowak JZ, Dejda A, Zawilska JB: Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) activate protein kinase C in chick cerebral cortex. Pol J Pharmacol, 2001, 53, 695-699.
17. Nowak JZ, Kuba K: Vasoactive intestinal peptide-stimulated adenosine 3′,5′-cyclic monophosphate formation in cerebral cortex and hypothalamus of chick and rat: comparison of the chicken and mammalian peptide. Neurosci Lett, 2001, 297, 93-96.
18. Nowak JZ, Kuba K, Zawilska JB: Stimulatory effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on cyclic AMP formation in the hypothalamus and cerebral cortex of four avians and rat. Pol J Pharmacol, 1999, 51, 195-199.
19. Nowak JZ, Pigułowska A, Kuba K, Zawilska JZ: Stimulatory effects of pituitary adenylate cyclase-activating polypeptide on inositol phosphates accumulation in avian cerebral cortex and hypothalamus. Neurosci Lett, 2002, 323, 179-182.
20. Nowak JZ, Sek B: Stimulatory effect of histamine on cyclic AMP formation in chick pineal gland. J Neurochem, 1994, 63, 1338-1354.
21. 3) histamine receptor subtype? Neurochem Int, 1995, 27, 519-526.
22. Nowak JZ, Sek B, Zawilska JB: A bizarre receptor mediating stimulatory effect of histamine on cyclic AMP formation in duck pineal gland. Neurosci Lett, 1995, 202, 65-68.
23. Nowak JZ, Woldan-Tambor A, Zawilska JB: Histaminergic and noradrenergic control of cyclic AMP formation in the pineal gland and cerebral cortex of three avian species: cock, duck and goose. Pol J Pharmacol, 1999, 50, 55-60.
24. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem, 2000, 275, 36781-36786.
25. Pratt BL, Takahashi JS: Vasoactive intestinal polypeptide and alpha-2 adrenoceptor agonists regulate adenosine 3′,5′-monophosphate accumulation and melatonin release in chick pineal cell cultures. Endocrinology, 1989, 125, 2375-2384.
26. Repka-Ramirez S: New concepts of histamine receptors and actions. Curr Allergy Asthma Rep, 2003, 3, 227-231.
27. Said SI, Mutt V: Polypeptide with broad biological activity: isolation from small intestine. Nature, 1970, 225, 863-864.
28. Salomon Y, Londos C, Rodbell M: A highly sensitive adenylate cyclase assay. Anal Biochem, 1974, 58, 541-548.
29. Schwartz J-C, Arrang JM, Garbarg M, Pollard H, Raut M: Histaminergic transmission in the mammalian brain. Physiol Rev, 1991, 71, 1-51.
30. Sharp PJ, Sterling RJ, Talbot RT, Huskisson NS: The role of hypothalamic vasoactive intestinal polypeptide in the maintenance of prolactin secretion in incubating bantam hens: observations using passive immunization, radioimmunoassay and immunohistochemistry. J Endocrinol, 1989, 122, 5-13.
31. Sherwood NM, Krueckl SL, McRory JE: The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev, 2000, 21, 619-670.
32. Shimizu H, Daly J, Creveling CR: A radioisotopic method for measuring the formation of adenosine 3′,5′-monophosphate in incubated slices of brain. J Neurochem, 1969, 16, 1609-1619
33. Talbot RT, Hanks MC, Sterling RJ, Sang HM, Sharp PJ: Pituitary prolactin messenger ribonucleic acid levels in incubating and laying hens: effects of manipulating plasma levels of vasoactive intestinal polypeptide. Endocrinology, 1991, 129, 496-502.
34. Tong Z, Pitts GR, You S, Foster DN, El Halawani ME: Vasoactive intestinal peptide stimulates turkey prolactin gene expression by increasing transcription rate and enhancing mRNA stability. J Mol Endocrinol, 1998, 21, 259-266.
35. Willems E, Knigge U, Jorgensen H, Kjaer A, Warberg J: Effect of selective blockade of catecholaminergic alpha and beta receptors on histamine-induced release of corticotropin and prolactin. Neuroendocrinology, 1999, 69, 309-315.
36. Willems E, Knigge U, Jorgenses H, Kjaer A, Warberg J: Effect of blockade of postsynaptic H1 or H2 receptors or activation of presynaptic H3 receptors on catecholamine-induced stimulation of ACTH and prolactin secretion. Eur J Endocrinol, 2000, 637-641.
37. You S, Hsu CC, Kim H, Kho Y, Choi YJ, El Halawani ME, Farris J, Foster DN: Molecular cloning and expression analysis of the turkey vasoactive intestinal peptide receptor. Gen Comp Endocrinol, 2001, 124, 53-65.
38. You S, Silsby JL, Farris J, Foster DN, El Halawani ME: Tissue-specific alternative splicing of turkey preprovasoactive intestinal messenger ribonucleic acid, its regulation, and correlation with prolactin secretion. Endocrinology, 1995, 136, 2602-2610.
39. Youngren O, Chaiseha Y, Phillips R, El Halawani ME: Vasoactive intestinal peptide concentrations in turkey hypophysial portal blood differ across the reproductive cycle. Gen Comp Endocrinol, 1996, 103, 323-330.
40. Zawilska JB, Niewiadomski P, Nowak JZ: Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptors in chick cerebral cortex. J Mol Neurosci, 2003, 20, 77-85.
41. 125I]-VIP binding and effects on cyclic AMP synthesis. Gen Comp Endocrinol, 2004, 137, 187-195.
42. Zawilska JB, Niewiadomski P, Nowak JZ: Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Pol J Pharmacol, 2004, 56, 203-211.
43. Zawilska JB, Woldan-Tambor A, Nowak JZ: Effects of histamine on phosphoinositide metabolism in chick cerebral cortex. Pol J Pharmacol, 2001, 53, 389-393.
44. 3H]tiotidine binding. J Neurochem, 2002, 81, 935-946.
45. 3H]tiotidine binding. Neurosci Lett, 2002, 319, 149-152.